A Study Of Advancing Diagnostics For Undiagnosed Diseases Through Multidisciplinary Collaboration

Overview

About this study

This study aims to diagnose individuals with undiagnosed rare diseases and learn new methodologies for diagnosing rare disease patients

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Referral from healthcare provider due to an undiagnosed condition.

  • Any age (although many will be under age 18)

  • Able to collect and send samples to the United States.

  • Able to provide informed consent or has a guardian/legal representative able to provide informed consent.

Exclusion Criteria:

  • Individuals with a confirmed diagnosis.

  • Cases deemed unsuitable for genomic or phenotypic analysis.

  • Inability to provide informed consent (or no consent obtained from guardian/legal representative)

  • Unable to collect and send samples to the United States.
    Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

    Eligibility last updated 5/12/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Eric Klee

Open for enrollment

Contact information:

Lindsay Mulvihill

(507) 538-5353

Mulvihill.Lindsay@mayo.edu

More information

Publications

Publications are currently not available